Sakar Healthcare Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 23, 2025. Further, the company has informed the Exchange regarding voting results.
SAKAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sakar Healthcare Limited held its 21st Annual General Meeting on September 23, 2025, via video conferencing, and all 7 resolutions were passed with overwhelming shareholder support. Key items approved include: adoption of audited standalone and consolidated financial statements for FY ended March 31, 2025 (100% in favour), re-appointment of Mr. Sunil Marathe as director retiring by rotation (100%), and ratification of cost auditor remuneration (100%). Three new independent directors—Ms. Megha Samdani, Ms. Reeya Kothari, and Ms. Hiral Patel—were appointed for 5-year terms (25 July 2025 to 24 July 2030), each receiving 99.99% approval. M/s. Nishant Pandya & Associates was also appointed as secretarial auditors for FY2025-26 to FY2029-30 (100% approval). Out of 22,249,910 total shares, 11,851,167 shares (53.26%) were polled, with dissent being negligible (between 0% and 0.01% across resolutions).
This is a routine regulatory disclosure with no material impact on shareholders or the stock price. The near-unanimous approval across all resolutions signals strong shareholder confidence in management and the board's composition.